Infectious diseases notes summarising all infectious pathologies for medical school examinations. Note there is also a slight excess in specialist knowledge for medical school examinations.
Look at specialty section and content list for the summary contents of this file.
Staphylococci
Description Pathology
- Commensal: Skin / nasal commensal in ~80 % - S. aureus
- Coagulase: +ve organisms are more severe infx. o Toxin: Scald Skin Syn. (Bullae + desquam.)
- NB: S. epidermidis commonest CVC infx isolate o Food Toxin: Sudden D&V within hours
Metabolic o Toxic Shock: ↑TO; ↓GCS; Rash; V&D; Tampon
- Gram Stain: Positive o Soft Tissue: Impetigo; Cellulitis; Mastitis
- Aerobic: Facultative Anaerobes o Bony Tissue: Septic arthritis; Osteomyelitis
- Enzymes: Catalase ± Coagulase - S. saprophyticus
Coagulase o GUT: UTI ➔ Cystitis
- +Ve: S. aureus - S. gallinarum
- -Ve: S. epidermis; S. saprophyticus; S. gallinarum o Eye: Endophthalmitis (rare)
Diagnosis Management
- MC&S: Take sample from site of infection - MSSA: Flucloxacillin
- Novobiocin: Can differentiate - MRSA: Glycopeptide; 4 % CHG + Nasal Mupirocin
- NB: epidermidis (sensitive); saprophyticus (resistant) - VRSA: Linezolid; 4 % CHG + Nasal Mupirocin
Enterococcus Faecalis (Formerly Group D Streptococcus)
Description Management
- Commensal: Gut commensals - Key. E. Faecalis is sensitive to ampicillin but E.
- NB: Enterococcus formerly known as Group D Strep. faecium is resistant
Pathology - Endocarditis: Amoxicillin/Benzylpenicillin + Gent.
- UTI: Over 30 % of all bacterial UTIs - Meningitis: Intrathecal vancomycin (NB: VRE exist)
- Endocarditis: Assume if detected in blood - UTI: Nitrofurantoin (regardless of VRE)
- Meningitis: Rare neurosurgical complication - AMR: Resistant to cephalosporins and quinolones
Streptococci
Description Pathology
- α-Haemolytic: Haemoglobin ➔ Biliverdin (green) - S. pneumoniae
- β-Haemolytic: Haemoglobin ➔ Complete haemolysis o Lungs: Pneumonia
- Grouping: Lancefield group of β-Haemolytic o ENT: Otitis media
Species - S. pyogenes
- Non-Haemolytic/Non-typable Lancefield: S. viridans o Systemic: Scarlet fever; Peripartum sepsis
- α-Haemolytic: S. pneumoniae; S. viridans o ENT: Tonsillitis; Pharyngitis;
- β-Haemolytic group A: S. Pyogenes o Skin: Impetigo; Erysipelas; Cellulitis; NF
- β-Haemolytic group B: S. agalactiae o Complications: RHD; GN; Toxic shock
- β-Haemolytic group D: S. gallolyticus; S. bovis - S. viridians
- β-Haemolytic group F: S. milleri complex o Heart: Endocarditis (from dental caries)
Management - S. gallolyticus
- Pneumonia: Amoxicillin o Heart: IE
- RHD: Penicillin V o Risks: Colon/Liver disease; CRC
- Skin: Fucloxacillin - S. milleri
- Endocarditis: Benzylpenicillin + Gentamicin o Abscesses: Lung; Liver; Bartholin’s
,Clostridia
Description Pathology
- Spores: Resilient Spores - C. difficile
- Aerobic: Obligate anaerobe o GI: Bowel infection – See relevant notes
- NB: C. botulinum can tolerate low levels of O2 - C. botulinum
Species o Nerve: Botulism – See relevant notes
- Gut: C. difficile - C. tetani
- Skin: C. perfringens (formerly C. welchii) o Nerve: Tetanus – See relevant notes
- Nerve: C. botulinum; C. tetani - C. perfringens
Management o Muscle/Skin: Gas/Fournier’s gangrene (α-toxin)
- Basic: Early recognition and surgical debridement o Sx: Crepitations heard over gangrene
- C. Diff: Metronidazole; Vancomycin; Fidaxomicin o Risks: GI surgery; Open fracture; malignancy
Diphtheria
Description Investigation
- Location: E. Europe; Russia; Asia - MC&S: Culture/PCR
Species - Serology: Toxin detection
- Species: Corynebacterium diphtheriae Management
Pathology - Key: Airway control
- Emergency: Tonsillar (grey) pseudomembrane - Antitoxin: Give within 48 hrs
- Sx: Fever; Odynophagia; Cervical lymphadenopathy - Abx: IM Benzylpenicillin / Erythromycin
Actinomycosis
Species Pathology
- Species: Actinomyces israelii - Subacute: Granulomatous/suppurative infx
Management - Location: Occurs adjacent to mucous membrane
- Abx: Penicillin - NB: Sulfur granules in pus/tissue characteristic
Neisseria meningitidis
Description Investigations
- Commensal: URT in 10 %; 25 % of teens - Microscopy: CSF; Blood; Skin lesion biopsy
- NB: Adheres to non-ciliated epithelial cells - NB: Intra/Extra-cellular diplococci
- Transmission: Aerosolized droplets Management
- Virulence: Serotypes ABCWY are virulent - Meningitis: Dexamethasone
- Microscopy: Gram negative diplococci - Prevention: Group B vaccination; ACWY at 14 YO
- Risks: Age; Complement defects; HIV; ↓Spleen - Abx: Ceftriaxone; Benzylpenicillin
Pathology - Prophylaxis: Ciprofloxacin/Ceftriaxone one dose
- Meningitis (50 % of cases) - Alternative: Rifampicin BD for 48 hrs
o Initial Sx: Headache; N&V; Malaise Complications
o Late Sx: Neck rigidity; Photophobia; ↓ GCS - Meningitis: ≥25 %; SNHL; Epilepsy
- Meningococcaemia - Systemic: AKI; ARDS; Thrombosis; Pneumonia
o Mild Sx: Fever; Macular rash; No shock signs
o Severe Sx: ↑To; Septic shock; Coagulopathy
Moraxella
Description Pathology
- Commensal: URT coloniser in children (↓ in adults) - Lungs: Bronchitis; Sinusitis; Laryngitis
- Risks: COPD; Elderly - ENT: Otitis media (esp. in children)
Species - Systemic: Septicaemia ➔ IE (20 % mortality)
- Species: Moraxella catarrhalis - MSK: Septic arthritis (rare)
Investigations Management
- MC&S: Sputum; Ear effusion; Sinus aspirate; Blood - Abx: Macrolide; Cephalosporin
- NB: Hockey puck sign (colonies move around on agar)
Escherichia coli
Description Pathology
- Commensal: Part of normal colonic flora - Enterotoxigenic: Traveller’s diarrhoea
- Pathogens: Many different pathogenic forms - Enterohaemorrhagic: D + haemorrhagic colitis
- Character: Facultative anaerobic; Lactose fermenter - Enteropathogenic: Esp. infants in poor sanitation
Management - Enteroinvasive: Dysentery-like syndrome
- Abx: TMP; Ampicillin; Cephalosporin; Ciprofloxacin - Enteroadherent: Traveller’s diarrhoea; Chronic D
- NB: ESBL and CRE commoner in E. coli strains - Extra-intestinal disease: Neo. sepsis; Pneumonia
Klebsiella pneumoniae
Description Pathology
- Commensal: Skin; Nasopharynx - Lungs: Pneumonia (alcoholics; Dysphagia pt.)
- Risks: Abx exposure; Catheter; ↓ Immunity - ENT: Nasopharyngitis
- NB: Very contagious in prolonged close quarters - GUT: UTI
Management - Complications: Sepsis + Necrosis if ↓ Immunity
- Abx: Aminoglycoside; Cephalosporin; Carbapenem
- Note: ESBL and CRE commoner in K. pneumoniae
Proteus mirabilis
Description Pathology
- Stones: Colonise stones formed in GUT - GUT: UTI (see Nephrolithiasis notes in urology)
- Metabolic: Urease which ↑ risk of stone formation - Risks: Struvite; Calcium oxalate; Uric acid stones
- Sex: More common in men - Complications: Renal calculi ➔ AKI
Presentation Management
- Signs: Alkaline urine; Fishy odour - Abx: Gentamicin; Carbapenems; Cephalosporins
Investigations - Resistant: Tetracycline; Nitrofurantoin
- Culture: Urine culture - NB: 10-20 % are resistant to ampicillin
- Microscopy: Characteristic swarming motility
Voordelen van het kopen van samenvattingen bij Stuvia op een rij:
Verzekerd van kwaliteit door reviews
Stuvia-klanten hebben meer dan 700.000 samenvattingen beoordeeld. Zo weet je zeker dat je de beste documenten koopt!
Snel en makkelijk kopen
Je betaalt supersnel en eenmalig met iDeal, creditcard of Stuvia-tegoed voor de samenvatting. Zonder lidmaatschap.
Focus op de essentie
Samenvattingen worden geschreven voor en door anderen. Daarom zijn de samenvattingen altijd betrouwbaar en actueel. Zo kom je snel tot de kern!
Veelgestelde vragen
Wat krijg ik als ik dit document koop?
Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.
Tevredenheidsgarantie: hoe werkt dat?
Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.
Van wie koop ik deze samenvatting?
Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper sk25. Stuvia faciliteert de betaling aan de verkoper.
Zit ik meteen vast aan een abonnement?
Nee, je koopt alleen deze samenvatting voor €10,50. Je zit daarna nergens aan vast.
